PL3689140T3 - Zwierzęta inne niż ludzie eksprymujące humanizowany kompleks CD3 - Google Patents

Zwierzęta inne niż ludzie eksprymujące humanizowany kompleks CD3

Info

Publication number
PL3689140T3
PL3689140T3 PL20160251.3T PL20160251T PL3689140T3 PL 3689140 T3 PL3689140 T3 PL 3689140T3 PL 20160251 T PL20160251 T PL 20160251T PL 3689140 T3 PL3689140 T3 PL 3689140T3
Authority
PL
Poland
Prior art keywords
complex
human animals
animals expressing
expressing humanized
humanized
Prior art date
Application number
PL20160251.3T
Other languages
English (en)
Inventor
Kara L. OLSON
Eric Smith
Ka-Man Venus Lai
Andrew J. Murphy
Gavin Thurston
Dayong Guo
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54849703&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3689140(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of PL3689140T3 publication Critical patent/PL3689140T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL20160251.3T 2014-11-24 2015-11-23 Zwierzęta inne niż ludzie eksprymujące humanizowany kompleks CD3 PL3689140T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462083653P 2014-11-24 2014-11-24
US201562106999P 2015-01-23 2015-01-23

Publications (1)

Publication Number Publication Date
PL3689140T3 true PL3689140T3 (pl) 2022-09-05

Family

ID=54849703

Family Applications (2)

Application Number Title Priority Date Filing Date
PL15808501T PL3223605T3 (pl) 2014-11-24 2015-11-23 Zwierzęta inne niż ludzie eksprymujące humanizowany kompleks CD3
PL20160251.3T PL3689140T3 (pl) 2014-11-24 2015-11-23 Zwierzęta inne niż ludzie eksprymujące humanizowany kompleks CD3

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL15808501T PL3223605T3 (pl) 2014-11-24 2015-11-23 Zwierzęta inne niż ludzie eksprymujące humanizowany kompleks CD3

Country Status (24)

Country Link
US (4) US20170164588A1 (pl)
EP (3) EP4088572A1 (pl)
JP (5) JP7018314B2 (pl)
KR (2) KR20240055876A (pl)
CN (2) CN107105633B (pl)
AU (2) AU2015353705C9 (pl)
BR (1) BR112017010793A2 (pl)
CA (1) CA2967823A1 (pl)
CY (1) CY1123714T1 (pl)
DK (2) DK3689140T3 (pl)
ES (2) ES2923775T3 (pl)
HR (2) HRP20220904T1 (pl)
HU (2) HUE052603T2 (pl)
IL (2) IL286414B2 (pl)
LT (2) LT3689140T (pl)
MA (1) MA50679A (pl)
MX (1) MX2017006802A (pl)
PL (2) PL3223605T3 (pl)
PT (2) PT3223605T (pl)
RS (2) RS61080B1 (pl)
RU (2) RU2020122439A (pl)
SG (1) SG11201703800PA (pl)
SI (2) SI3223605T1 (pl)
WO (1) WO2016085889A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107105633B (zh) * 2014-11-24 2021-02-12 瑞泽恩制药公司 表达人源化cd3复合物的非人类动物
CA2967834C (en) 2014-12-05 2024-01-16 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cluster of differentiation 47 gene
ES2982515T3 (es) 2014-12-09 2024-10-16 Regeneron Pharma Animales no humanos que tienen un gen del grupo de diferenciación 274 humanizado
US11612149B2 (en) 2015-07-10 2023-03-28 Chugai Seiyaku Kabushiki Kaisha Non-human animal having human CD3 gene substituted for endogenous CD3 gene
PL3376857T3 (pl) 2015-11-20 2021-09-13 Regeneron Pharmaceuticals, Inc. Zwierzęta inne niż człowiek posiadające humanizowany gen aktywacji limfocytów 3
SG11201807038UA (en) 2016-02-29 2018-09-27 Regeneron Pharma Rodents having a humanized tmprss gene
US11793180B2 (en) 2016-08-22 2023-10-24 Chugai Seiyaku Kabushiki Kaisha Gene-modified mouse expressing human GPC3 polypeptide
US11696572B2 (en) * 2017-06-27 2023-07-11 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ASGR1 locus
AU2018341685A1 (en) 2017-09-29 2020-04-02 Regeneron Pharmaceuticals, Inc. Non-human animals expressing humanized C1q complex
US11419318B2 (en) 2017-11-30 2022-08-23 Regeneran Pharmaceuticals, Inc. Genetically modified rat comprising a humanized TRKB locus
WO2019114768A1 (en) * 2017-12-12 2019-06-20 Biocytogen Jiangsu Co., Ltd. GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD3e
TW202431987A (zh) 2018-03-26 2024-08-16 美商再生元醫藥公司 用於測試治療藥劑之人類化囓齒動物
US10463029B1 (en) * 2018-06-07 2019-11-05 Regeneron Pharmaceuticals, Inc. Rodent model of steel syndrome
IL278267B1 (en) 2018-07-16 2024-10-01 Regeneron Pharma NON-HUMAN ANIMAL MODELS OF DITRA DISEASE AND USES THEREOF
CN109355309B (zh) * 2018-10-18 2021-02-05 江苏集萃药康生物科技股份有限公司 一种cd3e基因修饰人源化动物模型的构建方法
CN112300265B (zh) * 2019-07-29 2022-09-27 百奥赛图(北京)医药科技股份有限公司 Il33基因人源化的非人动物的构建方法和应用
CN114276433A (zh) * 2020-04-01 2022-04-05 百奥赛图(北京)医药科技股份有限公司 Cd38基因人源化的非人动物及其构建方法和应用
CA3176391A1 (en) * 2020-04-24 2021-10-28 Memorial Sloan-Kettering Cancer-Center Anti-cd3 antibodies and uses thereof
EP4240833A1 (en) * 2020-11-06 2023-09-13 BioVentures, LLC T cells and bifunctional protein against human papillomavirus
CN112458117B (zh) * 2021-02-02 2021-05-04 百奥赛图(北京)医药科技股份有限公司 Cd155基因人源化的非人动物的构建方法及应用
EP4294180A1 (en) * 2021-02-19 2023-12-27 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric cd3 genes
US20240277844A1 (en) 2023-02-17 2024-08-22 Regeneron Pharmaceuticals, Inc. Induced nk cells responsive to cd3/taa bispecific antibodies

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2096749T3 (es) * 1990-12-14 1997-03-16 Cell Genesys Inc Cadenas quimericas para vias de transduccion de señal asociada a un receptor.
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
FR2827302B1 (fr) 2001-07-13 2003-10-10 Genoway Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
ATE347593T1 (de) 2002-01-23 2006-12-15 Univ Utah Res Found Zielgerichtete chromosomale mutagenese mit zinkfingernukleasen
EP1344824A1 (en) * 2002-03-11 2003-09-17 Institut de la Santé et de la Recherche Médicale Mutated gene coding for a LAT protein and the biological applications thereof
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
UA94211C2 (ru) * 2004-06-03 2011-04-26 Новиммюн С.А. Выделенное полностью человеческое моноклональное cd3 антитело
DK2767161T3 (en) 2004-10-19 2018-05-07 Regeneron Pharma Method of generating an animal homozygous for genetic modification
KR101626988B1 (ko) 2007-04-03 2016-06-02 암젠 리서치 (뮌헨) 게엠베하 종간 특이적 이중특이적인 결합제들
PL2155783T5 (pl) * 2007-04-03 2023-03-13 Amgen Research (Munich) Gmbh Swoista międzygatunkowo domena wiążąca CD3epsilon
HUE040467T2 (hu) * 2007-04-03 2019-03-28 Amgen Res Munich Gmbh Keresztfaj-specifikus kötõdomén
US8632768B2 (en) * 2008-05-30 2014-01-21 University Of Louisville Research Foundation, Inc. Human facilitating cells
CA2738545A1 (en) * 2008-10-01 2010-04-08 Micromet Ag Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxcd3, igf-1rxcd3 or fapalpha xcd3 bispecific single chain antibody
EP2389443B1 (en) * 2009-01-23 2018-11-14 Roger Williams Hospital Retroviral vectors encoding multiple highly homologous non-viral polypeptides and the use of same
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
US20120117671A1 (en) 2009-07-31 2012-05-10 Hiroyuki Yoneyama Steatohepatitis-liver cancer model animal
US8883496B2 (en) * 2009-12-21 2014-11-11 Regeneron Phamaceuticals, Inc. Humanized FcgR mice
TW201125583A (en) * 2009-12-23 2011-08-01 Bioalliance Cv Anti-EpCAM antibodies that induce apoptosis of cancer cells and methods using same
NZ734532A (en) 2011-10-28 2022-12-23 Regeneron Pharma Genetically modified major histocompatibility complex mice
LT3272214T (lt) 2011-10-28 2020-03-10 Regeneron Pharmaceuticals, Inc. Genetiškai modifikuotos pelės, ekspresuojančios chimerines pagrindinio audinių dermės komplekso (mhc) ii molekules
RS61455B1 (sr) * 2011-10-28 2021-03-31 Regeneron Pharma Genetski modifikovani miševi t ćelijskog receptora
MY172726A (en) 2011-10-28 2019-12-11 Regeneron Pharma Humanized il-6 and il-6 receptor
WO2014028776A1 (en) * 2012-08-15 2014-02-20 Zyngenia, Inc. Monovalent and multivalent multispecific complexes and uses thereof
JP2015527357A (ja) * 2012-08-21 2015-09-17 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ 単一可変ドメインとカモスタットメシル酸塩（ｃｍ）とを含んでなる組成物
CN104797132B (zh) 2012-09-13 2017-06-30 中外制药株式会社 基因敲入非人动物
JOP20200236A1 (ar) 2012-09-21 2017-06-16 Regeneron Pharma الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
KR20150064068A (ko) * 2012-10-08 2015-06-10 로슈 글리카트 아게 2개의 Fab 단편을 포함하는 FC-부재 항체 및 이용 방법
IL311744A (en) 2012-11-05 2024-05-01 Regeneron Pharma Genetically modified non-human animals and methods of their use
TWI635098B (zh) 2013-02-01 2018-09-11 再生元醫藥公司 含嵌合恆定區之抗體
EP2958938B1 (en) 2013-02-20 2019-04-17 Regeneron Pharmaceuticals, Inc. Mice expressing humanized t-cell co-receptors
EP2958937B1 (en) 2013-02-22 2018-08-15 Regeneron Pharmaceuticals, Inc. Mice expressing humanized major histocompatibility complex
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
PL3175706T3 (pl) 2013-09-23 2019-05-31 Regeneron Pharma Zwierzęta inne niż człowiek mające humanizowany gen sygnałowego białka regulatorowego
CN103509122B (zh) * 2013-09-23 2015-04-15 武汉友芝友生物制药有限公司 一种cd3抗原及其制备方法和用途
SG10201900003WA (en) 2013-11-19 2019-02-27 Regeneron Pharma Non-human animals having a humanized b-cell activating factor gene
TWI754319B (zh) 2014-03-19 2022-02-01 美商再生元醫藥公司 用於腫瘤治療之方法及抗體組成物
SI3129400T1 (sl) 2014-04-08 2020-07-31 Regeneron Pharmaceuticals, Inc. Živali, ki niso človek in imajo humanizirane receptorje FC-gama
NO2785538T3 (pl) 2014-05-07 2018-08-04
WO2015179317A2 (en) 2014-05-19 2015-11-26 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals expressing human epo
SI3157956T1 (sl) 2014-06-19 2020-06-30 Regeneron Pharmaceuticals, Inc. Nehumane živali, ki imajo humaniziran gen programirane celične smrti 1
CN107105633B (zh) 2014-11-24 2021-02-12 瑞泽恩制药公司 表达人源化cd3复合物的非人类动物

Also Published As

Publication number Publication date
EP3689140B1 (en) 2022-05-11
AU2015353705B2 (en) 2022-01-20
RS61080B1 (sr) 2020-12-31
KR102659123B1 (ko) 2024-04-22
SG11201703800PA (en) 2017-06-29
AU2015353705C1 (en) 2022-08-11
PT3689140T (pt) 2022-07-27
ES2923775T3 (es) 2022-09-30
EP4088572A1 (en) 2022-11-16
AU2022202578A1 (en) 2022-05-12
RU2017122038A (ru) 2018-12-26
EP3223605B9 (en) 2021-08-18
DK3689140T3 (da) 2022-08-01
US20210100229A1 (en) 2021-04-08
CY1123714T1 (el) 2022-03-24
BR112017010793A2 (pt) 2017-12-26
MA50679A (fr) 2021-03-17
SI3689140T1 (sl) 2022-10-28
US20240306616A1 (en) 2024-09-19
PL3223605T3 (pl) 2021-04-19
EP3223605B1 (en) 2020-10-14
RU2017122038A3 (pl) 2019-07-17
RU2726446C2 (ru) 2020-07-14
AU2015353705C9 (en) 2022-09-01
DK3223605T3 (da) 2020-11-16
US20170164588A1 (en) 2017-06-15
LT3223605T (lt) 2021-01-11
US11937587B2 (en) 2024-03-26
JP2022066476A (ja) 2022-04-28
EP3689140A1 (en) 2020-08-05
LT3689140T (lt) 2022-08-25
CN107105633A (zh) 2017-08-29
SI3223605T1 (sl) 2021-03-31
IL286414A (en) 2021-10-31
CN107105633B (zh) 2021-02-12
MX2017006802A (es) 2018-01-30
RU2020122439A (ru) 2020-09-24
HUE059417T2 (hu) 2022-11-28
RS63410B1 (sr) 2022-08-31
ES2844000T3 (es) 2021-07-21
AU2015353705A1 (en) 2017-06-08
HRP20201938T1 (hr) 2021-02-05
US10932455B2 (en) 2021-03-02
EP3223605A1 (en) 2017-10-04
KR20240055876A (ko) 2024-04-29
JP2017536126A (ja) 2017-12-07
KR20170120090A (ko) 2017-10-30
JP2024114974A (ja) 2024-08-23
CN113016720B (zh) 2023-02-21
PT3223605T (pt) 2020-12-24
WO2016085889A1 (en) 2016-06-02
IL252202A0 (en) 2017-07-31
CN113016720A (zh) 2021-06-25
IL252202B (en) 2021-10-31
CA2967823A1 (en) 2016-06-02
IL286414B2 (en) 2024-04-01
JP7524240B2 (ja) 2024-07-29
JP2021035397A (ja) 2021-03-04
JP2023101757A (ja) 2023-07-21
JP7018314B2 (ja) 2022-02-10
JP7269214B2 (ja) 2023-05-08
US20200275642A1 (en) 2020-09-03
IL286414B1 (en) 2023-12-01
HRP20220904T1 (hr) 2022-10-14
HUE052603T2 (hu) 2021-05-28

Similar Documents

Publication Publication Date Title
IL286414A (en) Non-human animals expressing a cd3 complex of human origin
IL311371A (en) CD3 antibodies of human origin or chimeras
PL3130606T3 (pl) Przeciwciała dwuswoiste aktywujące układ odpornościowy
PT3101131T (pt) Anticorpo antitranstirretina humanizado
IL246497B (en) Non-human animals with human fc–gamma receptors
HUE046308T2 (hu) Humanizált KIR3DL2 ellenanyagok
SG11201610594WA (en) Anti-il4-il 13 bispecific antibodies
IL272676B (en) Bispecific antibodies against il-4 and il-13
GB201409990D0 (en) Loungers for pets